| Dr Zachary Hector-word, MD | |
|
217 S Madison Street, Traverse City, MI 49684 | |
| (231) 392-8400 | |
| (231) 935-7888 |
| Full Name | Dr Zachary Hector-word |
|---|---|
| Gender | Male |
| Speciality | Hematology/oncology |
| Experience | 20 Years |
| Location | 217 S Madison Street, Traverse City, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316064041 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 4301083656 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Munson Medical Center | Traverse city, MI | Hospital |
| Munson Healthcare Cadillac Hospital | Cadillac, MI | Hospital |
| Kalkaska Memorial Health Center | Kalkaska, MI | Hospital |
| Munson Healthcare Grayling Hospital | Grayling, MI | Hospital |
| Paul Oliver Memorial Hospital | Frankfort, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Munson Healthcare Cadillac | 6305161514 | 70 |
| Munson Medical Center | 3072426287 | 257 |
News Archive
An NIH funded multi-center clinical trial found no benefit from "maintenance therapy," low-dose peginterferon used for hepatitis C patients who have not responded to an initial round of treatment.
Obese patients with metastatic melanoma who are treated with targeted or immune therapies live significantly longer than those with a normal body mass index, investigators report in a study published in Lancet Oncology of 1,918 patients in six independent clinical cohorts.
Henry Ford Health System Innovations is supporting the Walgreens Balance Rewards App Challenge to find new mobile applications that incentivize healthy behavior and improve disease management.
It sounds like the plot of a 1950s science fiction movie: normal, helpful bacteria that begin to eat their host from within, because they don't get what they want.
Alnara Pharmaceuticals, a pharmaceutical company developing novel, non-systemic orally delivered protein therapeutics for the treatment of metabolic diseases, today announced results from an international, Phase 3 open-label, long-term safety study demonstrating the safety and nutritional benefits of liprotamase, a novel pancreatic enzyme replacement therapy (PERT) for patients with cystic fibrosis (CF).
› Verified 1 days ago
| Entity Name | Munson Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1083761860 PECOS PAC ID: 3072426287 Enrollment ID: O20040108000904 |
News Archive
An NIH funded multi-center clinical trial found no benefit from "maintenance therapy," low-dose peginterferon used for hepatitis C patients who have not responded to an initial round of treatment.
Obese patients with metastatic melanoma who are treated with targeted or immune therapies live significantly longer than those with a normal body mass index, investigators report in a study published in Lancet Oncology of 1,918 patients in six independent clinical cohorts.
Henry Ford Health System Innovations is supporting the Walgreens Balance Rewards App Challenge to find new mobile applications that incentivize healthy behavior and improve disease management.
It sounds like the plot of a 1950s science fiction movie: normal, helpful bacteria that begin to eat their host from within, because they don't get what they want.
Alnara Pharmaceuticals, a pharmaceutical company developing novel, non-systemic orally delivered protein therapeutics for the treatment of metabolic diseases, today announced results from an international, Phase 3 open-label, long-term safety study demonstrating the safety and nutritional benefits of liprotamase, a novel pancreatic enzyme replacement therapy (PERT) for patients with cystic fibrosis (CF).
› Verified 1 days ago
| Entity Name | Munson Healthcare Cadillac |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336539063 PECOS PAC ID: 6305161514 Enrollment ID: O20150401000808 |
News Archive
An NIH funded multi-center clinical trial found no benefit from "maintenance therapy," low-dose peginterferon used for hepatitis C patients who have not responded to an initial round of treatment.
Obese patients with metastatic melanoma who are treated with targeted or immune therapies live significantly longer than those with a normal body mass index, investigators report in a study published in Lancet Oncology of 1,918 patients in six independent clinical cohorts.
Henry Ford Health System Innovations is supporting the Walgreens Balance Rewards App Challenge to find new mobile applications that incentivize healthy behavior and improve disease management.
It sounds like the plot of a 1950s science fiction movie: normal, helpful bacteria that begin to eat their host from within, because they don't get what they want.
Alnara Pharmaceuticals, a pharmaceutical company developing novel, non-systemic orally delivered protein therapeutics for the treatment of metabolic diseases, today announced results from an international, Phase 3 open-label, long-term safety study demonstrating the safety and nutritional benefits of liprotamase, a novel pancreatic enzyme replacement therapy (PERT) for patients with cystic fibrosis (CF).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Zachary Hector-word, MD 2513 Momentum Pl, Chicago, IL 60689-5325 Ph: (231) 876-6080 | Dr Zachary Hector-word, MD 217 S Madison Street, Traverse City, MI 49684 Ph: (231) 392-8400 |
News Archive
An NIH funded multi-center clinical trial found no benefit from "maintenance therapy," low-dose peginterferon used for hepatitis C patients who have not responded to an initial round of treatment.
Obese patients with metastatic melanoma who are treated with targeted or immune therapies live significantly longer than those with a normal body mass index, investigators report in a study published in Lancet Oncology of 1,918 patients in six independent clinical cohorts.
Henry Ford Health System Innovations is supporting the Walgreens Balance Rewards App Challenge to find new mobile applications that incentivize healthy behavior and improve disease management.
It sounds like the plot of a 1950s science fiction movie: normal, helpful bacteria that begin to eat their host from within, because they don't get what they want.
Alnara Pharmaceuticals, a pharmaceutical company developing novel, non-systemic orally delivered protein therapeutics for the treatment of metabolic diseases, today announced results from an international, Phase 3 open-label, long-term safety study demonstrating the safety and nutritional benefits of liprotamase, a novel pancreatic enzyme replacement therapy (PERT) for patients with cystic fibrosis (CF).
› Verified 1 days ago
John P Milliken, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 224 Circle Dr, Traverse City, MI 49684 Phone: 231-935-0525 Fax: 231-935-0529 | |
Dr. David R Hendricks, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 153 1/2 E Front St, Traverse City, MI 49684 Phone: 231-941-6670 Fax: 231-941-6675 | |
Dr. Jill Elizabeth Vollbrecht, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5015 N Royal Dr, Traverse City, MI 49684 Phone: 231-935-0850 Fax: 231-935-0850 | |
Dr. Katrina Marie Lawrence-wolff, DO Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 3537 W Front St Ste A, Traverse City, MI 49684 Phone: 231-935-8330 Fax: 231-935-3437 | |
Steven M. Lamie, M. D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3537 W Front St, Suite I, Traverse City, MI 49684 Phone: 231-935-8950 Fax: 231-935-8868 | |
Anne M Hepner, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1200 Sixth St, Suite 200, Traverse City, MI 49684 Phone: 231-935-5800 Fax: 231-935-5799 | |
Mark V Galan, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 4100 Park Forest Dr, Suite 208, Traverse City, MI 49684 Phone: 231-935-5710 Fax: 231-935-9045 |